1.
Dabrafenib plus trametinib in patients with BRAF .sup.V600E-mutant low-grade and high-grade glioma : a multicentre, open-label, single-arm, phase 2, basket trial
by Wen, Patrick Y
The lancet oncology, 2022-01-01, Vol.23 (1), p.53
2.
National initiatives to improve outcomes from out-of-hospital cardiac arrest in England
by Perkins, Gavin D
Emergency medicine journal : EMJ, 2016-07, Vol.33 (7), p.448-451
3.
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating [kappa]-opioid antagonism as a treatment for anhedonia
by Krystal, Andrew D
Nature medicine, 2020-05-01, Vol.26 (5), p.760
4.
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF .sup.V600-mutant, stage III melanoma : exploratory biomarker analyses from a randomised, phase 3...
by Dummer, Reinhard
The lancet oncology, 2020-03-01, Vol.21 (3), p.358
5.
Correction to: Baroreflex activation therapy reduces frequency and duration of hypertensionârelated hospitalizations in patients with resistant hypertension
by Halbach, Marcel
Clinical autonomic research, 2021-12-01, Vol.31 (6), p.801
6.
A therapy for [beta]-thalassemia
by Stower, Hannah
Nature medicine, 2020-05-01, Vol.26 (5), p.649
7.
Primary medical therapy for BRAF.sup.V600E-mutant melanoma brain metastases -- is this good enough? - Authors' reply
by Davies, Michael A
The lancet oncology, 2017-09-01, Vol.18 (9), p.e509
8.
Primary medical therapy for BRAF.sup.V600E-mutant melanoma brain metastases -- is this good enough?
by Kruser, Tim J
The lancet oncology, 2017-09-01, Vol.18 (9), p.e508
9.
Preliminary results on response assessment using 68.sup.Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy
by Seitz, Anna Katharina
European journal of nuclear medicine and molecular imaging, 2018-04-01, Vol.45 (4), p.602
10.
An association between IL-1[beta] production and mitochondrial functions in patients with autism spectrum disorders
by Jyonouchi, Harumi
Journal of allergy and clinical immunology, 2017-02-01, Vol.139 (2), p.AB213
11.
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus : a randomised, phase 3, open-label, 2x2 factori...
by James, Roger D
The lancet oncology, 2013-05-01, Vol.14 (6), p.516-524
12.
Individualised 177.sup.Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
by Sundlov, Anna
European journal of nuclear medicine and molecular imaging, 2017-08-01, Vol.44 (9), p.1480
13.
Trastuzumab deruxtecan : a multicentre, open-label, phase 2 trial
by Siena, Salvatore
The lancet oncology, 2021-06-01, Vol.22 (6), p.779
14.
Correction to: Investigation of perfusion defects by QâSPECT/CT in patients with mildâtoâmoderate course of COVIDâ19 and low clinical probability for pulmonary embolism
by Ozturk, Buket Caliskaner
Annals of nuclear medicine, 2021-10-01, Vol.35 (10), p.1126
15.
Integrating Assertive Community Treatment and Illness Management and Recovery for Consumers with Severe Mental Illness
by Salyers, Michelle P
Community mental health journal, 2010-01-14, Vol.46 (4), p.319-329
16.
High detection rate in [[.sup.18]F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients
by Watabe, Tadashi
Annals of nuclear medicine, 2021-04-01, Vol.35 (4), p.523
17.
Altered expression of chemoattractant receptor-homologous molecule expressed on T.sub.H2 cells on blood basophils and eosinophils in patients with chronic spontaneous urticaria
by Oliver, Eric Tyrell
Journal of allergy and clinical immunology, 2016-01-01, Vol.137 (1), p.304
18.
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
by Zimmermann, Camilla, Dr
The Lancet (British edition), 2014, Vol.383 (9930), p.1721-1730
19.
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease
by Haworth, Charles S
Thorax, 2017-11-01, Vol.72 (11)
20.
Involvement of bradykinin [B.sub.2] and muscarinic receptors in the prolonged diuretic and antihypertensive properties of Echinodorus grandiflorus
by Prando, Thiago Buno Lima
Phytomedicine (Stuttgart), 2016-10-15, Vol.23 (11), p.1249
